Podcast 28 Apr 2023
Beyond Biotech podcast 43
This week’s podcast is sponsored by Scientist.com. The mainstream media in the past couple of months has picked up on artificial intelligence (AI). The coverage concentrates not so much on…
bit.bio
- Latest Posts
News and Trends 30 Nov 2022
bit.bio expands portfolio for drug discovery in neurodegenerative and neurological diseases
Cell coding company bit.bio has made three additions to its product portfolio: ioGlutamatergic Neurons MAPT N279K and ioGlutamatergic Neurons MAPT P301S disease models, and early access to its ioGABAergic Neurons.…
News and Trends 29 Sep 2022
Human cells can now help scientists accelerate cure for neurodegenerative diseases
Cell products providing a scalable source of human cells can now help scientists study neurogenerative diseases in human context. UK-based, cell-coding company, bit.bio announced the expansion to its portfolio today…
